These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11249591)

  • 21. In vitro activity of fluoroquinolones against gram-positive bacteria.
    Eliopoulos GM
    Drugs; 1995; 49 Suppl 2():48-57. PubMed ID: 8549407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The quinolones.
    Neu HC
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-fluorinated quinolones (NFQs): new antibacterials with unique properties against quinolone-resistant gram-positive pathogens.
    Roychoudhury S; Ledoussal B
    Curr Drug Targets Infect Disord; 2002 Mar; 2(1):51-65. PubMed ID: 12462153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel antibiotics active against Gram-positive bacteria].
    Garcia Sánchez JE; Fresnadillo Martínez MJ
    Rev Esp Quimioter; 2000 Dec; 13(4):344-51. PubMed ID: 11498700
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trovafloxacin].
    Azanza JR; Ollero D; Sádaba B; García Quetglas E
    Rev Med Univ Navarra; 1999; 43(1):45-57. PubMed ID: 10386346
    [No Abstract]   [Full Text] [Related]  

  • 27. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
    Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M
    J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintaining fluoroquinolone class efficacy: review of influencing factors.
    Scheld WM
    Emerg Infect Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12533274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoroquinolone resistance among Gram-positive cocci.
    Hooper DC
    Lancet Infect Dis; 2002 Sep; 2(9):530-8. PubMed ID: 12206969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms.
    Tarai B; Das P; Kumar D
    Indian J Med Microbiol; 2014; 32(3):353-4. PubMed ID: 25008844
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fluoroquinolones: a new era in antibiotic therapy?].
    Fiaccadori F
    Ann Ital Med Int; 1992; 7(1):46-50. PubMed ID: 1524947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of bacterial resistance to quinolones.
    Acar JF; O'Brien TF; Goldstein FW; Jones RN
    Drugs; 1993; 45 Suppl 3():24-8. PubMed ID: 7689447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone.
    Cho JC; Crotty MP; White BP; Worley MV
    Pharmacotherapy; 2018 Jan; 38(1):108-121. PubMed ID: 29059465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on cross-resistance of fluoroquinolones.
    Garau J
    Int J Clin Pract Suppl; 2000 Dec; (115):94-8. PubMed ID: 11219309
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones].
    Egorov AM; Sazykin IuO
    Antibiot Khimioter; 2001; 46(8):3-5. PubMed ID: 11871317
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluoroquinolones: action and resistance.
    Drlica K; Malik M
    Curr Top Med Chem; 2003; 3(3):249-82. PubMed ID: 12570763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of newer fluoroquinolones in vitro against gram-positive bacteria.
    Eliopoulos GM
    Drugs; 1999; 58 Suppl 2():23-8. PubMed ID: 10553701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New infective problems with old gram-positive pathogens: setting the stage.
    Sanders WE
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S1-2. PubMed ID: 7729465
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluoroquinolones.
    O'Donnell JA; Gelone SP
    Infect Dis Clin North Am; 2000 Jun; 14(2):489-513, xi. PubMed ID: 10829268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in bacterial resistance to fluoroquinolones.
    Acar JF; Goldstein FW
    Clin Infect Dis; 1997 Jan; 24 Suppl 1():S67-73. PubMed ID: 8994781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.